Leo has already posted an article stating that the market has not realized the real value of B and listed a private company that made a partnering deal for 250 million upfront for just an OM drug. We are partnering B for at least 2 indications upfront. I believe people are way off to the low side when it comes to the $ we get from a large Pharma. Nobody cares about the undervalued stock price when the assets and intellectual property that this company owns is worth many multiples of its current market cap.